Literature DB >> 11132733

Synthesis, modelling, and mu-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicycl.

G A Pinna1, G Murineddu, M M Curzu, S Villa, P Vianello, P A Borea, S Gessi, L Toma, D Colombo, G Cignarella.   

Abstract

A series of N-3-arylpropenyl-N-9-propionyl-3,9-diazabicyclo[3.3.1]nonanes (1a-g) and of reverted N-3-propionyl-N-9-arylpropenyl isomers (2a-g), as homologues of the previously reported analgesic 3,8-diazabicyclo[3.2.1]octanes (I-II), were synthesized and evaluated for the binding affinity towards opioid receptor subtypes mu, delta and kappa. Compounds 1a-g and 2a-g exhibited a strong selective mu-affinity with Ki values in the nanomolar range, which favourably compared with those of I and II. In addition, contrary to the trend observed for DBO-I, II, the mu-affinity of series 2 is markedly higher than that of the isomeric series 1. This aspect was discussed on the basis of the conformational studies performed on DBN which allowed hypotheses on the mode of interaction of these compounds with the mu receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132733     DOI: 10.1016/s0014-827x(00)00036-7

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  2 in total

1.  Rigid Scaffolds: Synthesis of 2,6-Bridged Piperazines with Functional Groups in all three Bridges.

Authors:  Donglin Gao; Christian Penno; Bernhard Wünsch
Journal:  ChemistryOpen       Date:  2020-08-27       Impact factor: 2.911

2.  Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity.

Authors:  L Legnani; D Colombo; A Venuti; C Pastori; L Lopalco; L Toma; M Mori; G Grazioso; S Villa
Journal:  Medchemcomm       Date:  2016-12-16       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.